Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Venus Concept ( (VERO) ) has provided an update.
On August 31, 2025, Venus Concept Inc. and its subsidiaries entered into several agreements with Madryn Health Partners to address liquidity requirements and loan maturity dates. The Consent Agreement waived certain minimum liquidity requirements under the MSLP Loan Agreement through September 30, 2025, while the Nineteenth Bridge Loan Amendment extended the maturity date of the Bridge Loan to September 30, 2025. Additionally, the Notes Consent Agreement waived liquidity requirements under the 2025 Notes, also through September 30, 2025. These agreements are aimed at providing financial relief and operational flexibility to Venus Concept Inc.
The most recent analyst rating on (VERO) stock is a Sell with a $2.00 price target. To see the full list of analyst forecasts on Venus Concept stock, see the VERO Stock Forecast page.
Spark’s Take on VERO Stock
According to Spark, TipRanks’ AI Analyst, VERO is a Underperform.
The most significant factor affecting the score is the company’s poor financial performance, characterized by high leverage, declining revenues, and substantial losses. Technical analysis also indicates bearish trends, further impacting the score. Valuation metrics are weak, with a negative P/E ratio and no dividend yield. While corporate events and earnings call provide some positive strategic developments, they are not enough to offset the financial and technical challenges.
To see Spark’s full report on VERO stock, click here.
More about Venus Concept
Average Trading Volume: 1,414,937
Technical Sentiment Signal: Strong Sell
Current Market Cap: $4.11M
See more insights into VERO stock on TipRanks’ Stock Analysis page.